Home / Events / How is China Shaping the Face of the Pharma Industry?
A laboratory technician in a white coat uses a pipette, in a laboratory.
Commercial UPCOMING WEBINAR

How is China Shaping the Face of the Pharma Industry?

Online

Discover how China’s growing influence in pharma is reshaping global R&D and partnerships in this exclusive webinar led by Scrip’s editorial team.

Explore one of the most dynamic shifts in the global pharmaceutical landscape with the editorial team behind Scrip. As China boosts R&D investment and strengthens international partnerships, the ripple effects are being felt across the globe.

This session will unpack the key drivers behind this evolution and what it means for pharma professionals worldwide.

Key talking points:

  • The rapid growth of China’s biopharmaceutical R&D
  • How new doors are opening for global collaboration
  • Opportunities and challenges for international companies

Meet the speakers
Headshot of Joseph Haas.
Joseph Haas
Senior Writer, US
Scrip
Headshot of Dexter Yan.
Dexter Yan
Senior Editor, China
Scrip
Headshot of Xu Hu.
Xu Hu
Senior Reporter, China
Scrip
Headshot of Andrew McConaghie.
Andrew McConaghie
Senior Writer, UK
Scrip
Joseph Haas
Senior Writer, US
 Scrip
Joe has covered a wide range of biopharmaceutical stories since 2007 and contributes to Scrip, In Vivo, Pink Sheet and related Citeline publications. His specialties include business development, commercial strategies and liver and infectious diseases.
Dexter Yan
Senior Editor, China
 Scrip
Dexter Yan is a senior writer covering China’s surging pharma industry on the APAC Pharma news team. With a keen interest in R&D and commercial activities taking place around the clock, he is always on the lookout for opportunities to keep readers better informed of any developments in the field.
Xu Hu
Senior Reporter, China
 Scrip
Xu is passionate about understanding information and knowledge related to biopharma industry. She is bilingual in Mandarin and English. Prior to this, Xu worked as a medical writer and wrote publications based on data from clinical trials for a wide range of therapeutic areas for global pharmaceutical companies. She holds a Master degree in Medical Pharmaceutical Science from University of Groningen and a PhD degree in Biomedical Science from Vrije Universiteit Amsterdam in the Netherlands.
Andrew McConaghie
Senior Writer, UK
 Scrip
Andrew writes on a range of topics across biopharma sector R&D and commercial issues, from new biotech start-ups to COVID-19 vaccines and new cancer, cell and gene therapies.
Register below
Citeline may contact you about relevant products, services, and content. To opt out of these communications or to manage what you receive, please visit our Preference Center.

Your information will be used in accordance with our Privacy notice.